armure emulsionskoncentrat
syngenta nordics a/s - difenoconazol, propiconazol - emulsionskoncentrat - 150 g/l difenoconazol ; 150 g/l propiconazol
libromide 325 mg tabletter
dechra regulatory b.v. - kaliumbromid - tabletter - 325 mg
glycopyrronium bromide "martindale" 200 mikrogram/ml injektionsvæske, opløsning
ethypharm - glycopyrroniumbromid - injektionsvæske, opløsning - 200 mikrogram/ml
vetbromide 600 mg tabletter
domes pharma - kaliumbromid - tabletter - 600 mg
rocuronium bromide "aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte
laboratoire aguettant - rocuroniumbromid - injektionsvæske, opløsning i fyldt injektionssprøjte - 10 mg/ml
thalidomide bms (previously thalidomide celgene)
bristol-myers squibb pharma eeig - thalidomid - multipelt myelom - immunosuppressiva - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.
thalidomide lipomed
lipomed gmbh - thalidomid - multipelt myelom - immunosuppressiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - bretaris genuair er indiceret som vedligeholdelsesbronkodilatorbehandling for at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (copd).
eklira genuair
covis pharma europe b.v. - aclidinium bromide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - eklira genuair er indiceret som vedligeholdelsesbronkodilatorbehandling for at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (copd).
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.